SCHEMBL3950005

SCHEMBL3950005

O[Ru]C1=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL52936 0.77
SCHEMBL14953811 0.74
SCHEMBL5569417 0.72
Carbon Monoxide SCHEMBL9218219 0.70
SCHEMBL7542500 0.69
SCHEMBL3339009 0.69
Carbon Monoxide SCHEMBL1981498 0.69
SCHEMBL4260534 0.69
SCHEMBL3006863 0.67
SCHEMBL3012180 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009019412-A1 RACEMISATION PROCESS FOR OBTAINING (1S,4S) N-METHYL-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENEAMINE (SERTRALINE) NPIL PHARMACEUTICALS (UK) LIMITED (GB) 2009-02-12 WO disclosed
US-7408082-B1 Racemisation process NPIL PHARMACEUTICALS (UK) LIMITED (GB) 2008-08-05 US disclosed